csl425
Vaccineexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2009 (NCT00938639)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- csl425
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00940108 | Phase 2 | Aug 1, 2009 | CSL Behring |
| NCT00958126 | Phase 2 | Aug 1, 2009 | CSL Behring |
| NCT00958243 | Phase 2 | Aug 1, 2009 | CSL Behring |
| NCT00938639 | Phase 2 | Jul 1, 2009 | CSL Behring |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CSL Behring | For profit | 4 | 4 | 1 | 2009 |
1 organizations
Page 1 / 1